Grail, the US-based cancer detection startup backed by billionaires Jeff Bezos and Bill Gates is reportedly mulling a launch on the Hong Kong stock exchange.
Karen Lightning-Jones, Integrated Franchise Leader at Roche Pipeline, speaks to pharmaphorum’s Linda Banks in Deep Dive: Digital II about how the company is applying data management and digital tools in the real world, and advancing genomic testing to improve treatment and outcomes in cancer.